A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee

Completed · Phase 3 · Has a placebo group

Conditions studied: Osteoarthritis, Chronic Pain

In brief

The purpose of this study is to evaluate the efficacy of Kadian NT (ALO-01) compared with placebo for treating moderate to severe chronic pain over a 12 week period.

Key facts

Study ID
NCT00420992
Run by
Pfizer
People needed
547
Starts
2006-12-01
Expected to finish
2007-11-01
Last updated by the study team
2013-09-20

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.